CCN1 and precursor B-cell acute lymphoblastic leukemia: According to the present and previous studies (Cao et al. 2019; Song et al. 2019), Cyr61 plays important roles in the drug resistance of B-ALL, and blocking the Cyr61 pathway may improve B-ALL treatment.